Literature DB >> 19686852

One-step chromatographic purification of human papillomavirus type 16 L1 protein from Saccharomyces cerevisiae.

Hyoung Jin Kim1, So Young Kim, Su Jeung Lim, Jin Young Kim, Seung Jae Lee, Hong-Jin Kim.   

Abstract

The prophylactic human papillomavirus vaccine is based on recombinant L1 protein produced in yeast or insect cells. L1 is a major capsid protein that self-assembles into virus-like particles (VLP). Conventionally, several chromatography steps are required to purify it; the steps are time consuming, and they result in losses of the target protein. Ultracentrifugation using a sucrose cushions or cesium chloride density gradients, and size-exclusion chromatography, has also been routinely used for small scale purification of L1 protein. However, these methods require a great deal of time and labor, and are not suitable for industrial-scale purification. To resolve these problems, we have developed two simple one-step chromatography methods for purifying recombinant HPV16 L1 protein produced in Saccharomyces cerevisiae. Eighty percent of the contaminating protein was removed by ammonium sulfate precipitation and by precipitating contaminants prior to the chromatography step. One method uses heparin chromatography and the other, cation-exchange chromatography, and recoveries by the two methods were both about 60%, the highest recoveries of L1 protein achieved so far. We confirmed that HPV16 L1 protein purified by either method self-assembles into VLP. We anticipate that these one-step chromatography methods will reduce the time, cost and labor needed for purification of L1 protein, and facilitate the study of prophylactic HPV vaccines. (c) 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19686852     DOI: 10.1016/j.pep.2009.08.005

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  11 in total

1.  The production and immunogenicity of human papillomavirus type 58 virus-like particles produced in Saccharomyces cerevisiae.

Authors:  Hye-Lim Kwag; Hyoung Jin Kim; Don Yong Chang; Hong-Jin Kim
Journal:  J Microbiol       Date:  2012-11-04       Impact factor: 3.422

2.  Association of antibody to E2 protein of human papillomavirus and p16INK4A with progression of HPV-infected cervical lesions.

Authors:  Jureeporn Chuerduangphui; Chamsai Pientong; Piyawut Swangphon; Sanguanchoke Luanratanakorn; Ussanee Sangkomkamhang; Thumwadee Tungsiriwattana; Pilaiwan Kleebkaow; Ati Burassakarn; Tipaya Ekalaksananan
Journal:  Med Oncol       Date:  2018-05-09       Impact factor: 3.064

3.  Development of an IP-Free Biotechnology Platform for Constitutive Production of HPV16 L1 Capsid Protein Using the Pichia pastoris PGK1 Promoter.

Authors:  F C Mariz; E C Coimbra; A L S Jesus; L M Nascimento; F A G Torres; A C Freitas
Journal:  Biomed Res Int       Date:  2015-05-18       Impact factor: 3.411

4.  The concentration of carbon source in the medium affects the quality of virus-like particles of human papillomavirus type 16 produced in Saccharomyces cerevisiae.

Authors:  Hyoung Jin Kim; Yingji Jin; Hong-Jin Kim
Journal:  PLoS One       Date:  2014-04-08       Impact factor: 3.240

5.  Increased Serum Antibody Titer against HPV-16 Antigen in Patients with Behçet's Disease.

Authors:  Kyu Yeun Kim; Do Young Kim; Jimyung Seo; Yuri Ahn; Dong Soo Kim
Journal:  J Korean Med Sci       Date:  2017-04       Impact factor: 2.153

Review 6.  Downstream processing of cell culture-derived virus particles.

Authors:  Michael W Wolf; Udo Reichl
Journal:  Expert Rev Vaccines       Date:  2011-10       Impact factor: 5.217

7.  The choice of resin-bound ligand affects the structure and immunogenicity of column-purified human papillomavirus type 16 virus-like particles.

Authors:  Hyoung Jin Kim; Su Jeung Lim; Hye-Lim Kwag; Hong-Jin Kim
Journal:  PLoS One       Date:  2012-04-26       Impact factor: 3.240

8.  Characterization of human papillomavirus type 16 pseudovirus containing histones.

Authors:  Hyoung Jin Kim; Hye-Lim Kwag; Hong-Jin Kim
Journal:  BMC Biotechnol       Date:  2016-08-27       Impact factor: 2.563

9.  Scalable Production of HPV16 L1 Protein and VLPs from Tobacco Leaves.

Authors:  Maryam Zahin; Joongho Joh; Sujita Khanal; Adam Husk; Hugh Mason; Heribert Warzecha; Shin-Je Ghim; Donald M Miller; Nobuyuki Matoba; Alfred Bennett Jenson
Journal:  PLoS One       Date:  2016-08-12       Impact factor: 3.240

Review 10.  Polysaccharide-based chromatographic adsorbents for virus purification and viral clearance.

Authors:  Guy-Alain Junter; Laurent Lebrun
Journal:  J Pharm Anal       Date:  2020-01-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.